Andrej Valkov

Author PubWeight™ 10.90^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Prognostic impact of lymphocytes in soft tissue sarcomas.	PLoS One	2011	1.06
2	Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.	PLoS One	2010	0.94
3	Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.	PLoS One	2012	0.90
4	Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer.	Prostate	2014	0.88
5	The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk.	BMC Clin Pathol	2014	0.87
6	Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas.	BMC Clin Pathol	2012	0.84
7	Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.	J Transl Med	2011	0.83
8	Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas.	BMC Clin Pathol	2013	0.82
9	Prognostic impacts of hypoxic markers in soft tissue sarcoma.	Sarcoma	2012	0.82
10	High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome.	BMC Clin Pathol	2014	0.81
11	Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific Survival.	Sarcoma	2011	0.79
12	High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator.	Oncoimmunology	2012	0.78
13	Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas.	BMC Clin Pathol	2012	0.76